(Bloomberg) GSK Plc will sell its remaining stake in Haleon Plc for £1.25 billion ($1.6 billion), completing the drugmaker’s separation from the consumer health company.Most Read from BloombergChina Attempts to End Property Crisis With Broad Rescue PackageUS Inflation Data Was Accidentally Released 30 Minutes EarlyWith a BlackRock CEO, $9 Trillion Vanguard Braces for TurbulencePutin and Xi Vow to Step Up Fight to Counter US ‘Containment’Jamie Dimon Sees ‘Lot of Inflationary Forces in Front of
LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.
Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for.
GSK Raises Outlook, Looks to New Medicines to Fuel Growth bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
TOP NEWS: GSK ups annual guidance on lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.